Illinois woman is the latest person in the U.S. to claim that the Biomet M2a Magnum Hip Implant is defective. An Illinois woman is the latest person in the U.S. to claim that the Biomet M2a Magnum Hip Implant is defective, that the manufacturer knew it, and that she’s been forced to undergo a painful and costly revision surgery to replace it.
This is the latest lawsuit to allege that a metal-on-metal hip implant is defective and that it caused a recipient to suffer unending pain, inflammation, and ultimately led them back to a surgeon to have it replaced in favor of another, more traditional device. The Biomet M2a Magnum Hip Implant has been identified as defective in a growing number of lawsuits and the Illinois woman in this case has turned to the national law firm of Parker Waichman LLP.
Parker Waichman has been picked by a growing number of metal-on-metal hip implant
Parker Waichman has been picked by a growing number of metal-on-metal hip implant recipients in the last few years. The firm stays on of the ever-changing headlines, federal alerts, and other legal news affecting tens of thousands of people who received the Biomet M2a Magnum Hip Implant or some other metal-on-metal hip implant in the last decade.
For the Illinois woman, she received the Biomet M2a Magnum Hip Implant in her right hip during a recent hip replacement procedure. Metal-on-metal hip implant recipients, including those of the Biomet M2a Magnum Hip Implant, are told that a metal-on-metal hip implant are more for younger recipients because they’re designed to last longer than traditional hip implants.
For thousands of recipients, likely tens of thousands, this claim is never realized an in either a few months or a few years, they’re experiencing a loosening of their hip implant that causes severe pain, inflammation, and eventual total failure of their hip implant. This is the pattern of pain and device failure that led the Illinois woman to ultimately have the Biomet M2a Magnum Hip Implant replaced.
In her complaint filed recently in U.S. District Court for the Northern District of Illinois
In her complaint filed recently in U.S. District Court for the Northern District of Illinois, she claims that Biomet had already become aware of at least 100 adverse event reports from recipients of the M2a Magnum device but the company failed to report these events to federal regulators and continued to market the hip implant as safe and effective.
The Illinois woman says she would have not agreed to be fitted with the M2a Magnum Hip Implant had she been aware of those adverse event reports from soon-to-be fellow recipients of the device.
She claims that in addition to the pain, the M2a Magnum also exposed her to dangerous levels of metallic ions that put her at risk of suffering metallosis, or metal poisoning, that has caused other recipients of metal-on-metal hip implants to suffer severe organ and tissue damage.
According to a release from Parker Waichman announcing the lawsuit, the Biomet device that’s subject of the complaint “uses a ‘monoblock’ system, there is no option to have an acetabular liner, forcing metal to rub against metal with the full weight of the body.”